Why it is important to continue antibacterial drug discovery. Combating resistance, improving safety, and preserving R&D teams are among reasons for persevering

ASM News

Volumn 70, Issue 6, 2004, Pages 282-287

  Bush, Karen ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3943076153     PISSN: 00447897     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)